Prologue Journal

Eli Lilly will spend $5.3 billion to boost manufacturing capacity for its anti-obesity drug Zepbound and cousin diabetes drug Mounjaro.

• prologu5
• 05/24/202405/24/2024

Wall Street Journal

Eli Lilly will spend $5.3 billion to boost manufacturing capacity for its anti-obesity drug Zepbound and cousin diabetes drug Mounjaro.

https://www.wsj.com/health/pharma/eli-lilly-boost-supply-mounjaro-zepbound-weight-loss-drugs-d7060ef2